Brian M. Wolpin
Advanced in Neuroendocrine Tumor
Advanced in Neuroendocrine Tumor

Overview

Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, and mechanisms by which lifestyle factors interact with malignant risk and progression.

Dr. Wolpin is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

His clinical research consists of co-authoring 244 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neuroendocrine Tumor.

Graduate Institution
Harvard Medical School, 2001|Harvard School Of Public Health, 2008
Residency
Brigham and Women's Hospital, 2001 - 2004
Specialties
Oncology
Licenses
Internal Medicine in MA
Board Certifications
Medical Oncology
Fellowships
Dana Farber Cancer Institute******, 2004 - 2007
Hospital Affiliations
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Dana-Farber Brigham Cancer Center in clinical affiliation with South Shore Health
101 Columbian Street, South, South Weymouth, MA 02190
Other Locations
Dana-Farber Cancer Institute - Chestnut Hill
300 Boylston Street, Chestnut Hill, MA 02459
Dana-Farber Cancer Institute, Center for Gastrointestinal Oncology
450 Brookline Avenue, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Randomized Phase 2 Study of Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Precision Promise Platform Trial for Metastatic Pancreatic Cancer
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Pancreatic Cancer
View 9 Less Clinical Trials
Similar Doctors
Elite in Neuroendocrine Tumor
Elite in Neuroendocrine Tumor
720 Harrison Ave, 
Boston, MA 
 (1.9 miles away)
Languages Spoken:
English
Accepting New Patients

Matthew Kulke is an Oncologist in Boston, Massachusetts. Dr. Kulke is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Liver Embolization. Dr. Kulke is currently accepting new patients.

Distinguished in Neuroendocrine Tumor
Oncology | Hematology
Distinguished in Neuroendocrine Tumor
Oncology | Hematology

The General Hospital Corporation

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
Languages Spoken:
English
Offers Telehealth

Lawrence Blaszkowsky is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Blaszkowsky is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Tissue Biopsy.

James A. Decaprio
Distinguished in Neuroendocrine Tumor
Distinguished in Neuroendocrine Tumor
44 Binney St, M457, 
Boston, MA 
 (0.1 miles away)
Languages Spoken:
English

James Decaprio is an Oncologist in Boston, Massachusetts. Dr. Decaprio is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Merkel Cell Carcinoma, Neuroendocrine Tumor, Retinoblastoma, Squamous Cell Skin Carcinoma, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wolpin's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile